Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Baylor College of Medicine
- Duke University
- Fred Hutchinson Cancer Center
- Stanford University
- University of Gdansk
- University of Washington
- Yale University
- CNRS
- Massachusetts Institute of Technology
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Florida
- University of Kentucky
- University of Minnesota
- Aarhus University
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Human Technopole
- Indiana University
- Institut Pasteur
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Macromolecular Chemistry CAS
- Lunds universitet
- Luxembourg Institute of Health
- MAYNOOTH UNIVERSITY
- Massachusetts Institute of Technology (MIT)
- Maynooth University
- Michigan State University
- Nencki Institute of Experimental Biology
- Pennsylvania State University
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- Rutgers University
- SUNY University at Buffalo
- St Jude Children's Research Hospital
- The Wistar Institute
- Umeå University
- University Hospital Magdeburg
- University of California San Diego - Ganesan Lab
- University of California, Los Angeles
- University of Colorado
- University of Kansas Medical Center
- University of Louisville
- University of Maryland, Baltimore
- University of Miami
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- Utrecht University
- Washington University in St. Louis
- 37 more »
- « less
-
Field
-
Posting Summary Rutgers, The State University of New Jersey is seeking a Postdoctoral Associate in Cancer Immunotherapy within the Department of Medical Immunology at the Rutgers Cancer Institute. A
-
biological efficacy of antibody-drug-conjugates or antibody-polymer-drug-conjugates in the treatment of cancer (immunotherapy) using the following experimental methods: Determination of cell viability using
-
University of California, Los Angeles | Los Angeles, California | United States | about 2 months ago
focuses on developing innovative technologies to enable in vivo cell engineering (e.g., in vivo CAR T cells) for immunotherapies against cancer, autoimmune disorders, and infectious diseases. The successful
-
investigate systemic immunity, the tumor microenvironment (TME), and the mechanistic drivers of resistance to radiation and immunotherapy utilizing advanced pre-clinical models of head/neck and pancreatic
-
assignment location. Be Bold. We are recruiting postdoctoral fellows in the following research areas: 1. Regenerative immunotherapy and CAR T-based approaches for tissue repair The postdoctoral fellow will
-
detects and kills cancer cells. We focus on understanding how human γδ T cells sense cellular stress in tumors, with the goal of developing novel and broadly accessible immunotherapies. We are seeking a
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
to develop new future types of immunotherapies. Our main area of interest is the regulation of immune response loci, such as interferon-stimulated genes (ISGs). In our research, we use techniques of chromatin
-
nanotechnology, molecular imaging, radiotherapy, and immunotherapy to create translational platforms for improved head and neck cancer treatment. The successful candidate will work on the design and synthesis
-
CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences | Austria | 2 months ago
, immunotherapy, cell engineering, and/or synthetic biology (Bock Lab , CeMM/MedUni Vienna). We develop and apply innovative technologies for analyzing immune memory (Krausgruber 2020 Nature ), for high-content